Sunitinib N-oxide

CAS: 356068-99-0

Ref. 3D-FS146111

Produktinformation

• Name: Sunitinib N-oxide
• Synonyme: N-[2-(Diethyloxidoamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide5 -(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethyl-N-oxoaminoe

Beschreibung

Sunitinib N-oxide is the active form of sunitinib, a drug that is used to treat cancer. Sunitinib N-oxide is a photolabile n-oxide and can be converted to sunitinib by exposure to light. This conversion process can be used as an analytical technique for determining the concentration of the drug in blood or tissue samples. Sunitinib N-oxide has been shown to reduce tumor growth in mouse models and also inhibits angiogenesis and tumor metastasis. The drug has also been shown to have anti-inflammatory effects, which may be due to its inhibition of prostaglandin synthesis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 414.47 g/mol
• Formel: C₂₂H₂₇FN₄O₃
• Reinheit: Min. 95%
• Farbe/Form: White Powder